Theradep Technologies, Inc.

Enbio Limited

Dow Corning Ireland Limited

Assure Medical Ltd. Co.

Liam O'Neill

John Gerard O'Donoghue

Peter Dobbyn

Joe O'Keeffe

Nick Evan Shephard

Frederic Gubbels

Andrew James Goodwin

Patrick Burt

Stuart Leadley

Lesley Ann O'Hare

Hugh Flood

Gerard O'Keeffe

Apoorva Shah

Caroline O'Sullivan

Barry Twomey

Kevin Roche

Paolo Vincenzo Ercole Fiorini

An urethral antimicrobial delivery device () comprising; a deformable reservoir () in fluid connection with an elongate member (), the elongate member comprising a lumen, the elongate member having a proximal end and a distal end, the elongate member having a plurality of pores () defined therein, said pores being distributed along a length of said elongate member, the elongate member being dimensioned for insertion through an external urethral orifice of a female subject, whereby the elongate member is insertable into a distal urethral cavity for delivery of an antimicrobial in said distal urethral cavity, and wherein the device comprises a collar () to prevent said elongate member entering a proximal urethral cavity.

Urethral delivery device

Plasma systems for depositing biomolecules, pharmaceutical agents, and other therapeutic active agents onto surfaces are described. The systems may include a plasma device having one or more electrodes, a gas supply inlet, a plasma outlet exposed to ambient pressure, and an ignition system operatively connected to the electrodes for providing a non-thermal equilibrium plasma within the plasma chamber. A particulate delivery system may be used to introduce the active agent(s) as a dry powder into or downstream of the plasma, and to deposit the plasma-treated active agent(s) to produce a coating on a surface. The coating may retain the activity of the active agent(s).

Systems and methods for delivering therapeutic agents

Methods for treating a bacterial infections, including drug-resistant bacterial infections, of a patient are described. The methods may include applying a non-thermal plasma and a liquid simultaneously to infected tissue of the patient, the liquid comprising at least one antibiotic and/or antiseptic and a penetration enhancing agent; wherein the non-thermal plasma has a frequency between 200 kHz and 600 kHz.

Methods of treating bacterial infections

A plasma coating device for treating a wound comprises a plasma chamber having: one or more electrodes, a gas supply inlet, a plasma outlet exposed to ambient pressure, and an ignition system operatively connected to the electrodes for providing a non-thermal equilibrium plasma within the plasma chamber. An aerosol delivery system is operable to introduce a bioresorbable material as an aerosol into the plasma, to produce a coating on the wound surface.

Wound healing device

A method of bonding an adherent to a substrate, wherein a primer is applied to the substrate by plasma deposition and the adherent is bonded to the primer treated surface of the substrate, and the primer contains functional groups which chemically bond to functional groups in the adherent.

Bonding an adherent to a substrate via a primer

The present invention is directed to methods for producing a coated substrate, including dissolving at least one biomolecule to form a solution; nebulizing the solution to form a liquid aerosol; combining the liquid aerosol and a plasma to form a coating; and depositing, in the absence of reactive monomers, the coating onto a substrate surface. In an aspect, the substrate can be an implantable medical device.

Implantable medical devices

Disclosed herein are methods of treating an article surface. The method comprises delivering a polymer and drug to a medical implant having a porous surface and using at least one particle stream from at least one fluid jet to subsequently remove the polymer from the outer surface of the metal substrate, thereby retaining the therapeutic agent and polymer within the pores of the implant.

Method for coating metal implants with therapeutic mixtures

A method for forming a polymeric coating on a substrate surface, by plasma treating a mixture comprising a free-radical initiated polymerisable monomer having one or more free-radical polymerisable groups in the presence of a free radical initiator, wherein said plasma treatment is a soft ionisation plasma process (a process wherein precursor molecules are not fragmented during the plasma process and as a consequence, the resulting polymeric coating has the physical properties of the precursor or bulk polymer) aid depositing the resulting polymeric coating material onto a substrate surface.

Growing community of inventors

Midleton, Ireland

Liam O'Neill